What do we know about Late Onset Huntington's Disease?
- PMID: 28671137
- PMCID: PMC5502838
- DOI: 10.3233/JHD-170247
What do we know about Late Onset Huntington's Disease?
Abstract
Background: Although the typical age of onset for Huntington's disease (HD) is in the fourth decade, between 4.4-11.5% of individuals with HD have a late onset (over 60 years of age). Diagnosis of Late onset HD (LoHD) can be missed, due to the perceived low likelihood of HD in the over 60-year-olds.
Objective: To review the epidemiology, genotype and phenotype of LoHD.
Methods: We systematically searched MEDLINE, EMBASE and Web of Science (inception-November 2016). Web of Science was then used to search for papers citing identified studies. Content experts were consulted for any additional studies. We included all studies reporting the clinical phenotype of LoHD for more than one participant.
Results: 20 studies were identified from a potential list of 1243. Among Caucasian HD cohorts, 4.4-11.5% of individuals have LoHD, and this proportion may be increasing. Proportion of LoHD without a positive family history ranges from 3-68%. 94.4% of reported cases of LoHD had CAG repeat lengths of ≤44. Motor manifestations are the commonest initial presentation, although 29.2% presented with non-motor manifestations as the first clinical feature in one case series. Individuals with LoHD may have slower progression of illness. Cognitive impairment rather than chorea may be the major source of disability in this group.
Conclusions: LoHD represents a substantial proportion of new diagnoses of HD and has some unique features. Further characterization of this population will aid clinicians in diagnosis.
Keywords: Huntington’s disease; aged; late onset Huntington’s disease; trinucleotide repeat expansion.
Similar articles
-
Comparison of mid-age-onset and late-onset Huntington's disease in Finnish patients.J Neurol. 2017 Oct;264(10):2095-2100. doi: 10.1007/s00415-017-8600-2. Epub 2017 Aug 28. J Neurol. 2017. PMID: 28849405
-
Clinical and genetic characteristics of late-onset Huntington's disease in a large European cohort.Eur J Neurol. 2022 Jul;29(7):1940-1951. doi: 10.1111/ene.15340. Epub 2022 Apr 17. Eur J Neurol. 2022. PMID: 35357736 Free PMC article.
-
Healthcare resource utilization and cost among individuals with late-onset versus adult-onset Huntington's disease: a claims‑based retrospective cohort study.J Med Econ. 2023 Jan-Dec;26(1):862-870. doi: 10.1080/13696998.2023.2228166. J Med Econ. 2023. PMID: 37350423
-
Huntington's disease like-2: review and update.Acta Neurol Taiwan. 2005 Mar;14(1):1-8. Acta Neurol Taiwan. 2005. PMID: 15835282 Review.
-
Onset and pre-onset studies to define the Huntington's disease natural history.Brain Res Bull. 2001 Oct-Nov 1;56(3-4):233-8. doi: 10.1016/s0361-9230(01)00648-7. Brain Res Bull. 2001. PMID: 11719256 Review.
Cited by
-
Coenzyme Q10: Role in Less Common Age-Related Disorders.Antioxidants (Basel). 2022 Nov 19;11(11):2293. doi: 10.3390/antiox11112293. Antioxidants (Basel). 2022. PMID: 36421479 Free PMC article. Review.
-
18F-FDG PET/CT: an unexpected case of Huntington's disease.BMC Neurol. 2019 May 1;19(1):78. doi: 10.1186/s12883-019-1311-9. BMC Neurol. 2019. PMID: 31043171 Free PMC article.
-
Influence of Age of Onset on Huntington's Disease Phenotype.Tremor Other Hyperkinet Mov (N Y). 2020 Jul 9;10:21. doi: 10.5334/tohm.536. Tremor Other Hyperkinet Mov (N Y). 2020. PMID: 32775035 Free PMC article.
-
Immune gene network of neurological diseases: Multiple sclerosis (MS), Alzheimer's disease (AD), Parkinson's disease (PD) and Huntington's disease (HD).Heliyon. 2021 Dec 1;7(12):e08518. doi: 10.1016/j.heliyon.2021.e08518. eCollection 2021 Dec. Heliyon. 2021. PMID: 34926857 Free PMC article.
-
Nmnat restores neuronal integrity by neutralizing mutant Huntingtin aggregate-induced progressive toxicity.Proc Natl Acad Sci U S A. 2019 Sep 17;116(38):19165-19175. doi: 10.1073/pnas.1904563116. Epub 2019 Sep 4. Proc Natl Acad Sci U S A. 2019. PMID: 31484760 Free PMC article.
References
-
- The Huntington’s Disease Collaborative Research Group. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington’s disease chromosomes. Cell. 1993;72(6):971–83. - PubMed
-
- Gómez-Tortosa E, del Barrio A, Ruiz PJG, Pernaute RS, Benítez J, Barroso A, et al. Severity of cognitive impairment in juvenile and late-onset Huntington disease. Arch Neurol. 1998;55(6):835–43. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical